vs
Axos Financial, Inc.（AX）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
Axos Financial, Inc.的季度营收约是CORCEPT THERAPEUTICS INC的1.9倍（$392.2M vs $202.1M），Axos Financial, Inc.净利率更高（31.8% vs 12.0%，领先19.8%），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 16.1%）
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
AX vs CORT — 直观对比
营收规模更大
AX
是对方的1.9倍
$202.1M
净利率更高
AX
高出19.8%
12.0%
两年增速更快
CORT
近两年复合增速
16.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $392.2M | $202.1M |
| 净利润 | $124.7M | $24.3M |
| 毛利率 | — | 98.7% |
| 营业利润率 | — | 2.2% |
| 净利率 | 31.8% | 12.0% |
| 营收同比 | — | 11.1% |
| 净利润同比 | 18.5% | -21.0% |
| 每股收益（稀释后） | $2.15 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXCORT
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $202.1M | ||
| Q3 25 | $323.4M | $207.6M | ||
| Q2 25 | $321.4M | $194.4M | ||
| Q1 25 | $308.8M | $157.2M | ||
| Q4 24 | $307.9M | $181.9M | ||
| Q3 24 | $320.7M | $182.5M | ||
| Q2 24 | $290.9M | $163.8M |
净利润AXCORT
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $24.3M | ||
| Q3 25 | $112.4M | $19.7M | ||
| Q2 25 | $110.7M | $35.1M | ||
| Q1 25 | $105.2M | $20.5M | ||
| Q4 24 | $104.7M | $30.7M | ||
| Q3 24 | $112.3M | $47.2M | ||
| Q2 24 | $104.9M | $35.5M |
毛利率AXCORT
| Q1 26 | — | — | ||
| Q4 25 | — | 98.7% | ||
| Q3 25 | — | 97.8% | ||
| Q2 25 | — | 98.2% | ||
| Q1 25 | — | 98.5% | ||
| Q4 24 | — | 98.4% | ||
| Q3 24 | — | 98.4% | ||
| Q2 24 | — | 98.5% |
营业利润率AXCORT
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | 2.2% | ||
| Q3 25 | 46.3% | 4.9% | ||
| Q2 25 | 48.5% | 13.7% | ||
| Q1 25 | 47.9% | 2.2% | ||
| Q4 24 | 48.8% | 13.9% | ||
| Q3 24 | 49.6% | 25.5% | ||
| Q2 24 | 49.6% | 21.7% |
净利率AXCORT
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | 12.0% | ||
| Q3 25 | 34.7% | 9.5% | ||
| Q2 25 | 34.4% | 18.1% | ||
| Q1 25 | 34.1% | 13.1% | ||
| Q4 24 | 34.0% | 16.9% | ||
| Q3 24 | 35.0% | 25.9% | ||
| Q2 24 | 36.0% | 21.7% |
每股收益（稀释后）AXCORT
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $0.20 | ||
| Q3 25 | $1.94 | $0.16 | ||
| Q2 25 | $1.89 | $0.29 | ||
| Q1 25 | $1.81 | $0.17 | ||
| Q4 24 | $1.80 | $0.25 | ||
| Q3 24 | $1.93 | $0.41 | ||
| Q2 24 | $1.75 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $372.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.1B | $647.8M |
| 总资产 | $29.2B | $836.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXCORT
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $372.2M | ||
| Q3 25 | $2.6B | $421.7M | ||
| Q2 25 | $1.9B | $342.2M | ||
| Q1 25 | $2.0B | $322.8M | ||
| Q4 24 | $2.4B | $383.3M | ||
| Q3 24 | $2.6B | $380.3M | ||
| Q2 24 | $2.0B | $473.2M |
总债务AXCORT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $312.7M | — | ||
| Q1 25 | $377.4M | — | ||
| Q4 24 | $358.7M | — | ||
| Q3 24 | $313.5M | — | ||
| Q2 24 | $325.7M | — |
股东权益AXCORT
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $647.8M | ||
| Q3 25 | $2.8B | $631.9M | ||
| Q2 25 | $2.7B | $635.8M | ||
| Q1 25 | $2.6B | $683.3M | ||
| Q4 24 | $2.5B | $679.6M | ||
| Q3 24 | $2.4B | $638.8M | ||
| Q2 24 | $2.3B | $596.2M |
总资产AXCORT
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $836.7M | ||
| Q3 25 | $27.4B | $823.6M | ||
| Q2 25 | $24.8B | $801.7M | ||
| Q1 25 | $24.0B | $846.5M | ||
| Q4 24 | $23.7B | $840.6M | ||
| Q3 24 | $23.6B | $784.3M | ||
| Q2 24 | $22.9B | $714.6M |
负债/权益比AXCORT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $38.4M |
| 自由现金流经营现金流 - 资本支出 | — | $38.4M |
| 自由现金流率自由现金流/营收 | — | 19.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.58× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXCORT
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $38.4M | ||
| Q3 25 | $118.4M | $54.5M | ||
| Q2 25 | $490.3M | $43.9M | ||
| Q1 25 | $73.7M | $5.1M | ||
| Q4 24 | $162.5M | $59.3M | ||
| Q3 24 | $70.8M | $73.8M | ||
| Q2 24 | $305.5M | $41.2M |
自由现金流AXCORT
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | $38.4M | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | $436.1M | $43.9M | ||
| Q1 25 | $65.1M | $5.0M | ||
| Q4 24 | $156.4M | $59.2M | ||
| Q3 24 | $53.0M | $72.2M | ||
| Q2 24 | $269.5M | $40.8M |
自由现金流率AXCORT
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | 19.0% | ||
| Q3 25 | 33.8% | — | ||
| Q2 25 | 135.7% | 22.6% | ||
| Q1 25 | 21.1% | 3.2% | ||
| Q4 24 | 50.8% | 32.5% | ||
| Q3 24 | 16.5% | 39.5% | ||
| Q2 24 | 92.6% | 24.9% |
资本支出强度AXCORT
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 16.9% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 2.0% | 0.1% | ||
| Q3 24 | 5.5% | 0.9% | ||
| Q2 24 | 12.4% | 0.3% |
现金转化率AXCORT
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | 1.58× | ||
| Q3 25 | 1.05× | 2.77× | ||
| Q2 25 | 4.43× | 1.25× | ||
| Q1 25 | 0.70× | 0.25× | ||
| Q4 24 | 1.55× | 1.93× | ||
| Q3 24 | 0.63× | 1.56× | ||
| Q2 24 | 2.91× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
CORT
暂无分部数据
